findmyKOL

Mark Metersky, MD

Enriched profile

Professor of Medicine; Associate Chief of Service, Department of Medicine; Chief, Division of Pulmonary, Critical Care and Sleep Medicine; Director, Center for Bronchiectasis Care · UConn Health

ORCIDNPI
Region🇺🇸 Farmington, CT · Northeast · United StatesSpecialtyPulmonary DiseaseFocusAsthma
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2024Online presenceverified 2026Payments2021–2025NIH funding1998–1999

Mark Metersky is Professor of Medicine; Associate Chief of Service, Department of Medicine; Chief, Division of Pulmonary, Critical Care and Sleep Medicine; Director, Center for Bronchiectasis Care at UConn Health. OpenAlex indexes 316 publications with 17,244 citations (h-index 47); ClinicalTrials.gov lists 2 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Pulmonary Disease profiles in the findmyKOL directory.

Data verified 14 Aug 2026

Overview

Updated 27 Aug 2026

Mark Metersky, MD, is Professor of Medicine at UConn Health (University of Connecticut School of Medicine), Farmington, Connecticut. The public record shows 316 publications with 17,244 citations (h-index 47), centered on Asthma. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 7 companies, 1 NIH-funded awards (1998–1999).

  • Most recent indexed publication: 2024 · Postgraduate medicine
  • Top research focus: Asthma
  • 2 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 7 companies

Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Asthma1 trialCough1 trialSjogren's Syndrome1 trial

Research focus

OpenAlex concept fingerprint
Asthma

Drugs & molecules

across trials, industry payments and publications
Arikaycegeneric · AmikacinClinical trialsIndustry payments1PublicationsNucalageneric · MepolizumabClinical trialsIndustry payments1Publications

Works with

trial sponsors and companies reporting payments
Insmed, Inc.Clinical trialsIndustry payments39Ethicon Inc.Clinical trialsIndustry payments4Pulmonx CorporationClinical trialsIndustry payments2

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
316publications

Distinct works indexed by OpenAlex, matched via ORCID; 17 in PubMed.

17,244citations

Total citations across indexed works.

47h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
2clinical trials

Investigator role on registered studies.

View trials
7companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments
1NIH grants · 1998–1999

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 27 Aug 2026

Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 27 Aug 2026

7 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Respiratory

    45.4%
    Corticosteroid21.1%
    Trelegy Ellipta26%Budesonide-Formoterol Fumarate22%Dulera17%Fluticasone Propionate13%Breo Ellipta12%Symbicort11%
    Part D<11 patients
    beta2-Adrenergic Agonist17.2%
    Albuterol Sulfate Hfa100%
    Part D30 patients
  • Anti-infectives

    27%
    Macrolide Antimicrobial14.4%
    Azithromycin100%
    Part D15 patients
    Tetracycline-class Drug3.7%
    Doxycycline Hyclate100%
    Part D17 patients
  • Nervous system

    10.1%
    Gabapentinoids5.1%
    Gabapentin100%
    Part D<11 patients
    Benzodiazepine2.8%
    Clonazepam100%
    Part D<11 patients
3 more therapeutic areas behind the reveal.Reveal →
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 27 Aug 2026

1 NIH research award on record, funded 19981999 per NIH RePORTER. The latest:

Publications

Updated 27 Aug 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Online presence

Updated 27 Aug 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/mark-metersky-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com
  • LinkedIn

    linkedin.com/in/mark-metersky-289a0b9

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com

Mentions by others

where others cite or feature them
  • Instagram

    instagram.com/p/DXbwSMqDvXq

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →instagram.com
  • Other

    themedicinementors.libsyn.com/the-power-of-humor-with-dr-mark-metersky

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →themedicinementors.libsyn.com

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 27 Aug 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • BA

    Biology, Franklin and Marshall College

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facultydirectory.uchc.edu
  • MD

    New York University School of Medicine

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facultydirectory.uchc.edu
  • Internship and Residency

    Internal Medicine, Boston City Hospital

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facultydirectory.uchc.edu
  • Fellowship

    Pulmonary and Critical Care Medicine, University of California San Diego Medical Center

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facultydirectory.uchc.edu
  • Fellow

    American College of Chest Physicians (FCCP)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facultydirectory.uchc.edu
  • Fellow

    American College of Physicians (FACP)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facultydirectory.uchc.edu

Editorial & leadership roles

journal and society appointments
  • Editorial Board Member

    CHEST journal

    2008
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facultydirectory.uchc.edu
  • Topic Editor

    DynaMed Plus

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facultydirectory.uchc.edu
  • Co-Chair

    international Pneumonia Guideline Committee (ATS/IDSA Community-Acquired Pneumonia Clinical Practice Guideline)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →academic.oup.com
1 more role behind the reveal.Reveal →

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances
  • Featured/quoted

    "New Drug Shows Promise for Treating Bronchiectasis," UConn Today

    2025
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →today.uconn.edu
  • Featured

    "Bronchiectasis Patient Shares Gratitude for His Pulmonologist and Power of Clinical Trials," UConn Today

    2025
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →today.uconn.edu
  • Video interview

    "The US Bronchiectasis and NTM Research Registry - aims and clinical developments," touchRESPIRATORY, ATS 2023

    2023
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →touchrespiratory.com
2 more media items behind the reveal.Reveal →

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.